Form 4: Concentrix CEO Sells Shares for Tax Obligations

Concentrix Corp's President and CEO, Christopher A. Caldwell, disposed of 5,693 shares of common stock at $37.35 per share to cover tax liabilities under a pre-arranged plan.

Summary

• Christopher A. Caldwell, President and CEO, and a Director of Concentrix Corp (CNXC), reported a transaction.
• On February 1, 2026, Caldwell disposed of 5,693 shares of Concentrix Common Stock.
• The shares were disposed of at a price of $37.35 per share.
• The transaction code 'F' indicates the disposition was for the payment of tax liability by delivering or withholding securities.
• The transaction was made pursuant to a Rule 10b5-1(c) pre-arranged plan.
• Following this transaction, Caldwell beneficially owns 356,382 shares of Concentrix Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The disposition of shares is for tax purposes under a pre-arranged plan, which is a routine administrative action and does not typically signal a change in company fundamentals or management's confidence.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to tax obligations or pre-arranged plans (Rule 10b5-1), are common occurrences and typically do not reflect a change in management's outlook on the company's performance or industry trends. This specific transaction is a routine compliance filing.

Stakeholder Impact

• Shareholders: The disposition of shares by a key executive, even for tax purposes, slightly reduces their direct ownership stake. However, given it's a tax-related sale under a 10b5-1 plan, it is generally not interpreted as a lack of confidence.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by the CEO to cover tax obligations, executed under a pre-arranged 10b5-1 plan. Such transactions are common and typically do not provide new fundamental information about the company's performance or future prospects. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Concentrix, CNXC, Insider Transaction, Form 4, Stock Sale, CEO, Tax Liability, Rule 10b5-1